After-Hours Stock Movers 10/27: (IFRX) (MIME) (F) Higher; (TWLO) (NTGR) (FLXE) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
InflaRx N.V. (IFRX) Surges 60% on Upgrade
October 28, 2021 8:58 AM EDTInflaRx N.V. (NASDAQ: IFRX) surges 59% in pre-open trade following the Raymond James upgrade to Strong Buy.
... MoreServiceNow (NOW) PT Raised to $725 at Stifel
October 28, 2021 8:06 AM EDTStifel analyst Tom Roderick raised the price target on ServiceNow (NYSE: NOW) to $725.00 (from $650.00) while maintaining a Buy rating.
The analyst commented, "The Digital Transformation era is solidly upon us, and it has become abundantly clear that ServiceNow is a foundational pillar of... More
Edwards Lifesciences (EW) PT Raised to $122 at Oppenheimer
October 28, 2021 7:46 AM EDTOppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $122.00 (from $120.00) while maintaining an Outperform rating.
The analyst commented, "Edwards reported 3Q21 revenues of $1.31B, slightly behind our/consensus' $1.34B/$1.32B estimates, but within guidance of $1.291.37B. TAVR... More
Impinj Inc (PI) PT Raised to $63 at Needham & Company
October 28, 2021 6:46 AM EDTNeedham & Company analyst James Ricchiuti raised the price target on Impinj Inc (NASDAQ: PI) to $63.00 (from $55.00) while maintaining a Buy rating.
The analyst commented, "PI posted better-than-expected Q3 results after the close, exceeding both revenue and earnings estimates despite ongoing supply constraints that... More
Edwards Lifesciences (EW) PT Raised to $129 at Stifel
October 28, 2021 6:42 AM EDTStifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $129.00 (from $120.00) while maintaining a Buy rating.
The analyst commented, "Despite pockets of OUS TAVR strength/recovery, US Covid impacts pushed 3Q21 revenues to $1.31B, just below Street... More
